Ampio Pharmaceuticals, Inc. (AMPE)

NYSEAMERICAN: AMPE · IEX Real-Time Price · USD
0.480 -0.015 (-3.03%)
Jan 21, 2022 4:00 PM EST - Market closed
Market Cap109.02M
Revenue (ttm)n/a
Net Income (ttm)-15.47M
Shares Out227.13M
EPS (ttm)-0.08
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,403,638
Open0.496
Previous Close0.495
Day's Range0.472 - 0.500
52-Week Range0.472 - 2.590
Beta1.49
AnalystsBuy
Price Target4.00 (+733.3%)
Earnings Daten/a

About AMPE

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunology-based therapies for the treatment of prevalent inflammatory conditions in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-016, an intravenous treatment that is in Phase I/II clinical trial for COVID-19 patients with respiratory illness; and AP-014, an inhaled treatment that is in Phase I clinical trial for COVID-19 induce...

IndustryPharmaceuticals
CEOMichael Macaluso
Employees18
Stock ExchangeNYSEAMERICAN
Ticker SymbolAMPE
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for AMPE stock is "Buy" and the 12-month stock price forecast is 4.00.

Price Target
$4.00
(733.33% upside)
Analyst Consensus: Buy

News

Ampio Pharmaceuticals Presents Corporate Overview at H.C. Wainwright Bioconnect Conference

ENGLEWOOD, Colo., Jan. 6, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory c...

2 weeks ago - PRNewsWire

Ampio Pharmaceuticals' CEO Mike Martino Issues Letter to Stockholders

ENGLEWOOD, Colo., Dec. 16, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammato...

1 month ago - PRNewsWire

Ampio (AMPE) Upgraded to Buy: Here's What You Should Know

Ampio (AMPE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 month ago - Zacks Investment Research

AMPIO PHARMACEUTICALS ANNOUNCES PRICING OF $22.5 MILLION REGISTERED DIRECT OFFERING

ENGLEWOOD, Colo., Dec. 13, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent infl...

1 month ago - PRNewsWire

Ampio Pharmaceuticals to Host Business Update Call with Chairman and CEO Mike Martino on Wednesday, Dec. 1

ENGLEWOOD, Colo., Nov. 29, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammato...

1 month ago - PRNewsWire

Ampio Pharmaceuticals Announces Shareholder / Business Update Call with its CEO & Chairman, Michael Martino

ENGLEWOOD, Colo., Nov. 23, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammato...

1 month ago - PRNewsWire

Board Member Michael Martino to Become Interim Chairman and CEO of Ampio Pharmaceuticals, Mike Macaluso to Take Medic...

ENGLEWOOD, Colo., Nov. 22, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for prevalent inflammato...

1 month ago - PRNewsWire

Down 25.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Ampio (AMPE)

The heavy selling pressure might have exhausted for Ampio (AMPE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in rev...

2 months ago - Zacks Investment Research

Ampio Pharmaceuticals, Inc. Announces Third Quarter 2021 Financial Results and Provides Business Update

ENGLEWOOD, Colo., Nov. 10, 2021 /PRNewswire/ --  Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for common inflam...

2 months ago - PRNewsWire

Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 Third Quarter Financial Results and Provide Corporate Business Update

ENGLEWOOD, Colo., Oct. 28, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammato...

2 months ago - PRNewsWire

Ampio Pharmaceuticals Strengthens Management Team and Board of Directors

ENGLEWOOD, Colo., Oct. 13, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for prevalent inflammato...

3 months ago - PRNewsWire

Ampio Pharmaceuticals Receives Approval from the Drugs Controller General of India (DCGI) to Commence AP-019 Phase II...

ENGLEWOOD, Colo., Sept. 21, 2021 /PRNewswire/ --  Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflamma...

4 months ago - PRNewsWire

Best Penny Stocks For Retail Traders to Buy? 3 For Your List

Investing in penny stocks right now? Check these three small caps out for your watchlist The post Best Penny Stocks For Retail Traders to Buy?

Other symbols:SHIPWTRH
4 months ago - PennyStocks

Penny Stocks For Your Biotech Watch List In September 2021

Penny stocks that may be worth watching right now. The post Penny Stocks For Your Biotech Watch List In September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:CASICFMSCLVS
4 months ago - PennyStocks

Ampio Pharmaceuticals Announces Top-line Results from AP-013 Phase III Study of Ampion in Adult Patients Suffering fr...

ENGLEWOOD, Colo., Sept. 15, 2021 /PRNewswire/ --  Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflamma...

4 months ago - PRNewsWire

Ampio Pharmaceuticals Announces Important New Research Manuscript on Anti-Inflammatory Mode of Action

ENGLEWOOD, Colo., Aug. 13, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent infl...

5 months ago - PRNewsWire

Ampio Pharmaceuticals Reminds Stockholders to Vote Shares in Advance of 2021 Annual Meeting

ENGLEWOOD, Colo., Aug. 12, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent infl...

5 months ago - PRNewsWire

Ampio Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences

ENGLEWOOD, Colo., Aug. 11, 2021 /PRNewswire/ --  Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inf...

5 months ago - PRNewsWire

Why Penny Stocks Investors Are Bullish on These 3 Small-Caps

Why penny stocks investors are showing bullish interest in these 3 small-caps The post Why Penny Stocks Investors Are Bullish on These 3 Small-Caps appeared first on Penny Stocks to Buy, Picks, News and...

Other symbols:CIDMSOS
5 months ago - PennyStocks

Here's Why Ampio Pharmaceuticals Stock Is Surging Today

A positive second-quarter earnings report and anticipation of further details to be discussed this afternoon helped this beaten-down biotech stock recover some previous losses.

5 months ago - The Motley Fool

Ampio Pharmaceuticals, Inc. Announces Second Quarter 2021 Financial Results and Provides Corporate Update

ENGLEWOOD, Colo., Aug. 4, 2021 /PRNewswire/ --  Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent infl...

5 months ago - PRNewsWire

Ampio Pharmaceuticals to Present at the American College of Toxicology 42nd Annual Meeting

ENGLEWOOD, Colo., July 29, 2021  /PRNewswire/ -- Ampio Pharmaceuticals  (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflamma...

5 months ago - PRNewsWire

Ampio Pharmaceuticals to Present at the 14th International Congress on Systemic Lupus Erythematosus (LUPUS 2021) & 6t...

ENGLEWOOD, Colo., July 28, 2021 /PRNewswire/ --  Ampio Pharmaceuticals  (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflamma...

5 months ago - PRNewsWire

Ampio Pharmaceuticals to Present at Aspen Lung Conference

ENGLEWOOD, Colo., July 27, 2021 /PRNewswire/ --  Ampio Pharmaceuticals  (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflamma...

5 months ago - PRNewsWire

Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 Second Quarter Financial Results and Provide Corporate Business Update

ENGLEWOOD, Colo., July 14, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammato...

6 months ago - PRNewsWire